The Role of Microbiome-Based Therapeutics in Clostridioides difficile Infection: Durable, Long-Term Results of RBX2660
Crossref DOI link: https://doi.org/10.1007/s40121-022-00714-9
Published Online: 2022-11-07
Published Print: 2023-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Orenstein, Robert http://orcid.org/0000-0001-5210-1258
Funding for this research was provided by:
Ferring Pharmaceuticals
Text and Data Mining valid from 2022-11-07
Version of Record valid from 2022-11-07
Article History
Received: 20 May 2022
Accepted: 5 October 2022
First Online: 7 November 2022